Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg (Extended Release) Tablets

Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg (Extended Release) Tablets About

GLIDAPA TENMET 1000 is a modern and effective combination medication designed for the management of Type 2 Diabetes Mellitus. It contains Dapagliflozin 10 mg, Teneligliptin 20 mg, and Metformin Hydrochloride 1000 mg (Extended Release)a powerful triple-action formula that helps control blood sugar levels through complementary mechanisms.

This advanced combination is ideal for patients who require multi-drug therapy to achieve optimal glycemic control. By targeting different pathways involved in glucose regulation, GLIDAPA TENMET 1000 not only helps reduce blood sugar levels but also supports long-term metabolic health and reduces the risk of diabetes-related complications.

Uses

GLIDAPA TENMET 1000 is primarily used for the treatment of Type 2 Diabetes Mellitus, especially in patients who are not adequately controlled with diet, exercise, or single/dual therapy.

It helps in:

• Lowering high blood glucose levels
• Improving insulin sensitivity
• Reducing glucose reabsorption in kidneys
• Enhancing incretin hormone activity for better insulin release
• Supporting overall glycemic control

This medication is typically prescribed as part of a comprehensive diabetes management plan that includes a healthy diet and regular physical activity.

Benefits

The combination of Dapagliflozin, Teneligliptin, and Metformin Hydrochloride Extended Release provides multiple benefits:

1. Triple Mechanism Action Targets blood sugar through kidney excretion, insulin secretion, and reduced glucose production in the liver.
2. Effective Glycemic Control Helps maintain stable blood sugar levels throughout the day.
3. Weight Management Support Dapagliflozin may aid in mild weight reduction by eliminating excess glucose through urine.
4. Improved Patient Compliance Three medicines combined into one tablet reduce pill burden.
5. Cardiovascular and Renal Benefits Supports heart and kidney health in diabetic patients.
6. Extended Release Advantage Metformin ER ensures sustained glucose control with fewer gastrointestinal side effects.

Dosage

The dosage of GLIDAPA TENMET 1000 should be strictly followed as prescribed by a healthcare professional.

• Usually taken once daily, preferably with meals to minimize stomach discomfort.
• Swallow the tablet whole with water; do not crush or chew, as it is an extended-release formulation.
• Maintain consistent timing each day for best results.

Important tips:

• Monitor blood glucose levels regularly.
• Follow dietary and lifestyle recommendations alongside medication.
• Do not skip doses or discontinue without consulting your doctor.

Side Effects

While GLIDAPA TENMET 1000 is generally well-tolerated, some patients may experience mild to moderate side effects:

• Nausea or stomach discomfort
• Frequent urination (due to Dapagliflozin)
• Headache or dizziness
• Low blood sugar (especially when combined with other antidiabetic medicines)
• Genital or urinary tract infections

Rare but serious side effects may include lactic acidosis (associated with Metformin), severe dehydration, or allergic reactions. Immediate medical attention is required if symptoms like severe weakness, difficulty breathing, or swelling occur.

Precautions and Warnings

Before starting GLIDAPA TENMET 1000, consider the following precautions:

• Kidney Function: Patients with impaired kidney function should use this medication cautiously.
• Liver Disorders: Inform your doctor if you have liver disease.
• Hydration: Maintain adequate fluid intake to avoid dehydration.
• Alcohol Consumption: Limit alcohol intake, as it may increase the risk of side effects like lactic acidosis.
• Pregnancy & Breastfeeding: Use only if prescribed by a doctor.
• Infections: Monitor for signs of urinary or genital infections.

Patients should also inform their healthcare provider about any other medications or supplements they are taking to avoid potential drug interactions.

Conclusion

GLIDAPA TENMET 1000 is a highly effective triple-combination therapy that offers comprehensive blood sugar control for patients with Type 2 Diabetes Mellitus. With the combined power of Dapagliflozin, Teneligliptin, and Metformin Hydrochloride Extended Release, it addresses multiple aspects of diabetes management, ensuring better outcomes and improved quality of life.

When used as prescribed along with a balanced diet and regular exercise, GLIDAPA TENMET 1000 can help patients achieve stable glucose levels, reduce complications, and maintain long-term health. It stands as a reliable and advanced solution for modern diabetes care.